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Abstract 1 
Hyperspectral chemical imaging (HCI) is an emerging technique which combines 2 
spectroscopy with imaging. Unlike traditional point spectroscopy, which is used in the 3 
majority of polymer biomaterial degradation studies, HCI enables the acquisition of spatially 4 
localised spectra across the surface of a material in an objective manner. Here, we 5 
demonstrate that attenuated total reflectance Fourier transform infra-red (ATR-FTIR) HCI 6 
reveals spatial variation in the degradation of implantable polycarbonate urethane (PCU) 7 
biomaterials. It is also shown that HCI can detect possible defects in biomaterial formulation 8 
or specimen production; these spatially resolved images reveal regional or scattered spatial 9 
heterogeneity. Further, we demonstrate a map sampling method, which can be used in 10 
time-sensitive scenarios, allowing for the investigation of degradation across a larger 11 
component or component area. Unlike imaging, mapping does not produce a contiguous 12 
image, yet grants an insight into the spatial heterogeneity of the biomaterial across a larger 13 
area. These novel applications of HCI demonstrate its ability to assist in the detection of 14 
defective manufacturing components and lead to a deeper understanding of how a 15 
biomaterial’s chemical structure changes due to implantation.  16 
Keywords: Biomaterial characterisation, biostability, hyperspectral chemical imaging, in vivo 17 
degradation, polycarbonate urethane. 18 
 19 
20 
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1. Introduction 1 
A biomaterial is a material intended to interface with biological systems to evaluate, treat, 2 
augment or replace any tissue, organ or function of the body [1]. The human body is an 3 
aggressive environment for biomaterials [2] and may have an adverse effect on the 4 
performance of these materials [3]. To gain an understanding of the failure mechanisms  5 
associated with the in vivo performance of an implanted device (and its biomaterial 6 
components), it is important to examine explanted (retrieved) devices [4]. Mechanical wear 7 
and damage characterisation are important in retrieval analysis studies, however, 8 
investigations relating to changes to chemical structure due to the biological environment 9 
are equally necessary [4]. Long-term implantable polymers are an important class of 10 
biomaterials, used in a variety of biomedical applications [5]. In particular, the polyurethane 11 
(PU) group, and more specifically polycarbonate urethanes (PCU), are used in vascular 12 
catheters [6,7] and orthopaedic [8–11] applications. Though PCU has been shown to be 13 
more biostable than polyether urethanes (PEU) [12,13], another polymer in the PU group 14 
used in cardiovascular applications [14], PCU components of explanted orthopaedic 15 
implants have been reported to degrade in the human body due to oxidation [9,15]. This 16 
oxidative degradation results in the cleavage of chemical bonds in a polymer [16] and has 17 
been shown to adversely affect the surface chemical structure of the PCU spacer of the 18 
Dynesys spinal stabilisation device (Zimmer, Warsaw, Indiana, USA) [9,15,17,18]. To 19 
replicate and understand the effect of in vivo oxidation on chemical structure, an 20 
accelerated in vitro oxidation method to degrade PCU biomaterials has been reported 21 
[8,12,19]. This process produces hydroxyl radicals from the H2O2/CoCl2 solution and is 22 
reported to be an appropriate model of the in vivo processes which produce oxygen radicals 23 
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at the polymer/cell interface [20]. By using this in vitro degradation method, it was shown 1 
that oxidative degradation also affects the viscoelastic properties of the BDyn spinal 2 
stabilisation device (S14 Implants, Pessac, France), and its components, at specific 3 
frequencies [8]. 4 
Fourier transform infra-red (FTIR) spectroscopy is one of the three recommended 5 
techniques to quantify the chemical structure of polymers according to the ISO standard 6 
10993-18, in addition to nuclear magnetic resonance (NMR) spectroscopy and mass 7 
spectroscopy (MS). Attenuated total reflectance Fourier transform infra-red (ATR-FTIR) 8 
spectroscopy has been used to understand and characterise the chemical structure changes 9 
of films [12,19,21–23], tubing [21], dumbbell or cylindrical specimen shapes [24–28], 10 
pacemaker or defibrillator leads [14,29] and orthopaedic devices [8,9,15,17,18]. A major 11 
limitation of standard ATR-FTIR, as conventionally applied, is that spectra are usually 12 
acquired from a single point of a sample. This risks missing critical information of how, and 13 
the extent to which, degradation varies across an explant spatially, as well as potential 14 
operator bias in the selection of an acquisition point on an explanted component. To 15 
overcome these potential risks, the acquisition of spatially resolved chemical data is 16 
desirable. Hyperspectral chemical imaging (HCI) is an emerging technique which combines 17 
spectroscopy with imaging, enabling the acquisition of spatially localised spectra across the 18 
surface of a material [30,31]. The feasibility of mid-infrared HCI has been demonstrated for 19 
high-throughput, non-destructive monitoring of biochemical processes directly at the 20 
cellular level [32], evaluation of the molecular state of polymer matrices for drug release 21 
[33] and protein adsorption on monolayers [34]. ATR-FTIR HCI enables the acquisition of 22 
spectra from the surface of samples that would otherwise be too thick for conventional mid-23 
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IR spectroscopy. A tutorial on the acquisition of hyperspectral chemical images and 1 
subsequent computational analysis (through both Matlab and R) has been previously 2 
presented [35]. However, to the best of the authors’ knowledge, the potential of this 3 
technique for evaluation of surface variations in the degradation of long-term implantable 4 
biomaterials has not been evaluated. Here, we demonstrate that ATR-FTIR HCI reveals 5 
spatial variations in the degradation of polymer biomaterials. Two long-term implantable 6 
PCUs (Bionate II 80A and ChronoFlex C 80A) were degraded by two different in vitro 7 
oxidation methods. Comparisons, based on HCI data, were made between the untreated 8 
specimens and specimens degraded through in vitro oxidation. Further, this study 9 
investigated and reports variations of the in vivo degradation of an explanted biomaterial 10 
component from an orthopaedic device using HCI.  11 
2. Materials and methods 12 
2.1 Biomaterials  13 
Bionate II 80A (DSM, Heerlen, Netherlands) and ChronoFlex C 80A (AdvanSource 14 
Biomaterials, Wilmington, MA, USA) are commercially available long term implantable 15 
polycarbonate urethane (PCU) biomaterials. These were gathered in pellet form and 16 
injection moulded into 150 mm x 150 mm sized plaques [36] with a thickness of 3 mm ± 0.2 17 
mm according to the individual manufacturers’ recommendations. As per implantation 18 
protocols, the plaques were sterilised by Ethylene Oxide (EtO) (Steriservices, Bernay, 19 
France). This process involves three cycles with an EtO concentration of 600 mg/L for 4 20 
hours at 43 °C. No separate aeration was implemented as aeration was performed in the 21 
chamber. The plaques were then cut into the defined ASTM D1708 specimen shape [37] by 22 
using a die cutter (Wallace Instruments, Cambridge, UK) on a Wallace Hand Operated 23 
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Specimen Cutting Press (Wallace Instruments, Cambridge, UK). From each plaque, 23 1 
specimens were cut.  Once a plaque was cut, the specimens were numbered and a random 2 
order generator (Excel 2010, Microsoft, Redmond, Washington, USA) was used to separate 3 
the specimens into untreated (n=6), 3% H2O2 (n=6) and 20% H2O2 / 0.1M (n=6) groups.  4 
2.2 In vitro degradation of biomaterials 5 
30% hydrogen peroxide (H2O2) Fisher Scientific, Loughborough, United Kingdom) and 0.1M 6 
cobalt (II) chloride hexahydrate (CoCl2.6H2O) (Sigma Aldrich, Dorset, United Kingdom) were 7 
used in the preparation of the oxidative degradation solutions. The 30% H2O2 was diluted to 8 
the appropriate 3% H2O2 and 20% H2O2 concentration levels using deionized water [13]. 9 
The ISO 10993-13 method was followed to degrade Bionate II 80A and ChronoFlex C 80A 10 
with 3% H2O2. Oxidative degradation of the biomaterials was performed at 37°C ± 1°C in a 11 
water bath (JB5 Water Bath, Grant Instruments, Cambridgeshire, United Kingdom). The 12 
solution was changed every seven days and the degradation period was 52 weeks. The 13 
solution did not include any metal ions to catalyse the decomposition of the hydrogen 14 
peroxide [24]. After the degradation period, the specimens were rinsed with deionised 15 
water and dried under vacuum for 48 hours at room temperature. 16 
The commonly used accelerated oxidation method [8,12,19] was also used to degrade the 17 
PCU biomaterials with 20% H2O2/0.1M CoCl2.6H2O. To maintain a relatively constant 18 
concentration of radicals [19], the H2O2/CoCl2.6H2O solution was changed every three days 19 
while the degradation period lasted 24 days. Similar to the ISO 10993 method, accelerated 20 
oxidative degradation was performed at 37°C ± 1°C in a water bath (JBN18 Water Bath, 21 
Grant Instruments, Cambridgeshire, United Kingdom). After the degradation period, the 22 
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specimens were rinsed with deionised water and were dried under vacuum for 48 hours at 1 
room temperature.  2 
2.3 BDyn Posterior Dynamic Stabilisation device  3 
The BDyn Posterior Dynamic Stabilisation (PDS) device (S14 Implants, Pessac, France) is a 4 
bilateral system designed to preserve intersegmental range of motion, reduce intradiscal 5 
pressure and alleviate loading of the facet joints [11]. It comprises of a polycarbonate 6 
urethane ring (Bionate II 80A, DSM, Heerlen, The Netherlands) and a silicone cushion (MED-7 
4770, NuSil Technology LLC, Carpinteria, CA, USA), a mobile titanium alloy rod, a fixed 8 
titanium alloy rod and is fixed to the vertebrae by titanium alloy pedicle screws [11]. The 9 
BDyn explant was sent to S14 Implants (Pessac, France) after complications with the device. 10 
The titanium alloy housing was carefully cut along a laser weld to expose the PCU and 11 
silicone components and the components were sterilised. Patient details were 12 
unobtainable, however, the estimated implantation time (based on distribution of implants 13 
to retrieval surgery date) was approximately six months.  14 
2.4 Hyperspectral Chemical Imaging  15 
A Thermo Scientific™ Nicolet™ iN™10 Infrared Microscope (10× magnification, Mercury-16 
Cadmium-Tellurium (MCT) detector, working range 4000-675 cm-1 with a 2 cm-1 spectral 17 
resolution) was used in combination with a slide-on Germanium ATR Micro Tip to collect 18 
ATR-FTIR hyperspectral chemical images. The system was nitrogen gas purged for an hour 19 
before use and the purge was maintained during use. The detector was a liquid nitrogen 20 
cooled and allowed to equilibrate for an hour before use. This was also maintained during 21 
acquisition. Specimens were attached to glass slides and inserted into the instrument. A 22 
white light mosaic image was collected to aid with hyperspectral collection. 23 
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2.4.1 Imaging of in vitro degraded biomaterials  1 
A detector aperture size of 200 μm was selected, and the resultant spatial resolution of the 2 
ATR Micro Tip using the single point detector was 50 μm. After selecting a region of interest 3 
in the centre of each biomaterial sample, grids of data points were selected such that the 4 
distance between each pixel was 50 μm, in order to generate spatially contiguous images. 5 
Pixel acquisition time was ~11.2 seconds and images were 1296 pixels in size resulting in a 6 
total acquisition time of ~4 hours (typically the collective acquisition times of x spectra will 7 
be approximately x times longer than the collection of a single spectrum). 8 
2.4.2 Imaging of in vivo degraded explant  9 
An aperture size of 150 μm was selected, and the resultant spatial resolution of the ATR 10 
Micro Tip using the single point detector was 37.5 μm. After selecting a region of interest in 11 
the explant specimen, a grid of data points was selected such that the distance between 12 
each pixel was 100 μm, in order to generate a spatially resolved (non-contiguous) 13 
hyperspectral chemical map.  14 
2.4.3 Raman mapping 15 
In order to independently corroborate the ATR-FTIR results, identical areas of Bionate II 80A 16 
materials were analysed using both ATR-FTIR and Raman spectroscopy mapping. These 17 
materials were from the same experimental batch as the in vitro studies described above in 18 
section 2.2 but were examined 6 months after the original experimental protocol and after 19 
subsequent mechanical testing of the samples. 20 
Raman maps were acquired using an inVia Micro-Raman confocal spectroscopy system 21 
(Renishaw, Wotton-under-Edge, Gloucestershire, UK) with a 10x 0.25NA objective lens, 785 22 
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nm edge laser (laser power was 306 mW at source, and was set to 1% power for sample 1 
measurements) and an 600 line mm-1 grating without pinhole.  Spectra were calibrated to a 2 
silicon shift at 520 cm-1. The detector used was a NIR enhanced Deep Depletion CCD array 3 
(1024 × 256 pixels) which was Peltier cooled to -70°C. The spectral range was 3035.3 cm-1 - 4 
1089.1 cm-1 with a mean spectral resolution of 1.9231 cm-1 over 1013 measured spectral 5 
bands. As contiguous Raman imaging over a similar area to the ATR images was not feasible 6 
within a reasonable timeframe, areas were mapped rather than imaged (using a step size of 7 
15 μm). The laser footprint was rectangular/oval in shape, with the longer dimension 8 
mapping to the vertical direction of the generated Raman map. As the step size was equal in 9 
X and Y directions, this resulted in a vertically directed elongated appearance in features of 10 
the Raman images.  11 
ATR-FTIR imaging parameters were as described in section 2.4.1.   12 
2.5 Pre-processing 13 
ATR-FTIR spectra were pre-processed as described below. The spectral range was cut to 14 
2000 cm-1 - 675 cm-1. The spectra were then scaled to a stable aromatic C-H out of plane 15 
bending peak at 819 cm-1 [9]. Linear baseline correction was subsequently performed and 16 
followed by a baseline shift of one arbitrary unit.  A peak at ~1591-1596 cm-1 indicative of 17 
C=C bond stretching of an aromatic ring of the hard segment [12,21,23,38] has been 18 
reported to remain unchanged in PCU oxidation [39], and has therefore been used as 19 
internal reference peak in the literature. However such an approach is not suitable in the 20 
present instance as a neighbouring peak overlaps the C=C stretching peak and consistency 21 
of its intensity between spectra cannot be assumed. In other studies PCU spectra have been 22 
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normalised to an aromatic internal reference peak at 508 cm-1 [4], however this was outside 1 
of the measured range. 2 
Internal normalisation was not possible in the case of the in vivo specimen image due to the 3 
disappearance of the 819 cm-1 peak in highly degraded regions. For this reason, SNV 4 
normalisation (spectrum-wise mean subtraction with spectrum-wise division by standard 5 
deviation) was used in the case of the in vivo image. 6 
No pre-processing was applied to the Raman spectra. 7 
2.6 Data analysis 8 
The mean spectrum was calculated for each image and randomised sample spectra were 9 
inspected. Randomisation was achieved through the “rand” function of Matlab. Histograms 10 
were produced at wavenumbers of interest in order to assess the shape of absorbance 11 
distributions. ATR images at particular wavenumbers of interest were inspected.  12 
Peak ratio images were also generated. The ratio between peaks reported to be indicative 13 
of degradation (1650 cm-1 (growing): aromatic amine and 1248 cm-1 (shrinking): carbonate 14 
[12,17,21]) were calculated and resultant dimensionless ratio value images were generated. 15 
Trends in these images were compared to the trends of the single wavenumber images. 16 
The “parula” (blue → green → yellow) colour scale was used for the image generation of all 17 
in vitro images as this colour scale ranges from dark to bright incrementally. This is an 18 
important consideration as colour scales which do not possess this property can result in 19 
human error when arbitrary dramatic colour changes cause the observer to believe a 20 
greater difference exists than is actually the case. The “hot” colour scale was used in all 21 
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overlaid in vivo maps as this colour scale increments from dark to bright but also contrasts 1 
well with the white-light image onto which it has been overlaid. 2 
Multivariate analysis was conducted in relation to in vitro specimens only. Reference spectra 3 
were chosen to represent both degraded and undegraded materials. The mean control 4 
spectrum (B0) was chosen as an undegraded reference spectrum, while the mean spectrum 5 
of the material exposed to the harshest oxidation technique (B20) was chosen as a 6 
degraded reference spectrum. The undegraded reference spectrum was then subtracted 7 
from the degraded reference spectrum to produce a difference spectrum which highlights 8 
features associated with degradation. Each HCI (B0, B3 and B20 in vitro Bionate II 80A 9 
images) was then projected along the difference spectrum, by multiplying the HCI spectra by 10 
the difference spectrum, and converting each pixel-spectrum to a single index 11 
representative of the level of degradation. A histogram was produced to assess the 12 
distribution of these indices and to select threshold points for separation of groups of pixels 13 
into classes according to degradation level. Finally, the degradation classes were visualised 14 
as images and the mean spectrum of each class was inspected. The time taken to process 15 
the data (including initial loading and image generation) was 28.5seconds, on Windows 10 16 
running Matlab 2017b. 17 
2.7 Statistical analysis 18 
Each HCI comprised 1296 spectra. Descriptive statistics, i.e. the sample means and standard 19 
deviations of the intensities of the peaks of interest (1174 cm-1, 1248 cm-1 and 1650 cm-1) 20 
were calculated from each image.  21 
22 
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3. Results 1 
3.1 Univariate analysis of Bionate II (in vitro degradation) 2 
The mean spectra of the hyperspectral chemical images of control (B0), 3% H2O2 (B3) and 3 
20% H2O2/0.1M CoCl2.6H2O (B20) treatments for Bionate II 80A (DSM, Heerlen, Netherlands) 4 
were calculated (Fig. 1). As reported in the literature [12,17,21] 1174 cm-1  is indicative of C-5 
C cross-linking, 1248 cm-1 is indicative of C-O-C carbonate bonds, and 1650 cm-1 is indicative 6 
of aromatic amines (Supplementary Table 1). It was found that little to no C-C cross-linking 7 
peak exists at 1174 cm-1 in the mean spectra of the B0 and B3 specimens, while a small yet 8 
notable peak emerges in the B20 specimen mean spectrum. Further, it is evident that the 9 
carbonate peak at 1248 cm-1 decreased in the B20 specimen relative to the B0 and B3 10 
specimens, suggesting degradation of the carbonate soft segment. Finally, no aromatic 11 
amine peak or band was detected at 1650 cm-1 in the mean spectra of B0 and B3, however, 12 
a subtle band is visible in the B20 mean spectrum. 13 
13 
 
 1 
Figure 1. Image mean spectra of B0 (top), B3 (middle) and B20 (bottom) for Bionate II 80A. Colour bars have 2 
been added to indicate the spectral ranges associated with polycarbonate urethane degradation (1174 cm
-1 3 
[range: 1183 cm
-1
 to 1160 cm
-1
]: C-C cross-linking, 1248 cm
-1 
[range: 1260 cm
-1
 to 1235 cm
-1
]: C-O-C 4 
carbonate, and 1650 cm
-1
 [range: 1662 cm
-1
 to 1630 cm
-1
]: aromatic amine) (Supplementary Table 1). 5 
 6 
To inspect whether the mean spectrum is an accurate representation of each specimen, 100 7 
spectra were randomly selected from each hyperspectral chemical image (Fig. 2). While B0 8 
14 
 
and B3 show little variability between spectra (and their corresponding mean spectra shown 1 
in Fig. 1), this is not the case for the B20 spectra which exhibit considerable variability within 2 
the sample, particularly in the case of the aromatic amine peak at 1650 cm-1 and the 3 
carbonate peak at 1248 cm-1.  4 
5 
Figure 2. 100 randomised spectra from hyperspectral chemical image of B0 (top), B3 (middle) and B20 6 
(bottom) for Bionate II 80A. Colour bars have been added to indicate the spectral ranges associated with 7 
polycarbonate urethane degradation (1174 cm
-1 
[range: 1183 cm
-1
 to 1160 cm
-1
]: C-C cross-linking, 1248 cm
-1 8 
15 
 
[range: 1260 cm
-1
 to 1235 cm
-1
]: C-O-C carbonate, and 1650 cm
-1
 [range: 1662 cm
-1
 to 1630 cm
-1
]: aromatic 1 
amine). 2 
To further investigate heterogeneities in each sample, single wavenumber images were 3 
generated at the wavenumbers reported to be related to degradation [12,24], accompanied 4 
by corresponding histograms (Fig. 3, Supplementary Fig. 1 and Supplementary Fig. 2). From 5 
visual inspection, no C-C cross-linking (at 1174 cm-1) was detected in the B0 and B3 images 6 
(Fig. 3). However, the entire imaged surface of the B20 specimen has experienced C-C cross-7 
linking. Interestingly, the degree to which C-C cross-linking has occurred is highly variable. In 8 
the case of B0 and B3, the histogram (Fig. 3, bottom right) shows a mono-modal distribution 9 
in relation to 1174 cm-1. These distributions appear to substantially overlap, with similar 10 
means (1.45 and 1.43) and standard deviations (0.02 and 0.02) for B0 and B3 respectively, 11 
while the B20 sample had a larger mean (2.15) and standard deviation (0.19). A bi-modal 12 
distribution at 1174 cm-1 can be observed in the case of B20, suggesting that there are at 13 
least two degradation populations in the B20 specimen. The corresponding B20 image (Fig. 14 
3, bottom left) reveals the spatial arrangement of these degradation populations.  15 
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 1 
Figure 3. Images of B0 (top left), B3 (top right) and B20 (bottom left), with accompanying histogram (bottom 2 
right) depicting relative absorbance at 1174 cm
-1
.  Image colour scale from 1
st
 to 99
th
 percentile. 3 
The distribution of the 1248 cm-1 carbonate peak varied across the surface of all samples 4 
(Supplementary Fig. 1). The histogram demonstrates a mono-modal distribution in the case 5 
of both B0 and B3, which have similar means (7.58 and 7.42) and similar standard deviations 6 
(0.18 and 0.20), while B20 has in this case a smaller mean (6.61) and larger standard 7 
deviation (1.08). Once again, in the case of B20, a bi-modal distribution is visible in the 8 
histogram (Supplementary Fig. 1, bottom right) which is spatially resolved in the 9 
accompanying image (Supplementary Fig. 1, bottom left). While, from the histogram, it 10 
appears that there is a mono-modal 1248 cm-1 distribution in the case of B0 and B3, several 11 
pixels of their corresponding 1248 cm-1 images (Supplementary Fig. 1, top left and right 12 
respectively) appear to be of lower intensity than the majority, suggesting small scattered 13 
regions of carbonate soft segment degradation. These regions are not clearly distinguishable 14 
in the histogram due to their scarcity. Equivalently, left and central regions of the B20 1248 15 
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cm-1 image (Supplementary Fig. 1, bottom left) comprise pixels of considerably higher 1 
intensity (brighter pixels) than the image mean, suggesting a lack of carbonate degradation 2 
in this region. An emerging peak at 1650 cm-1, associated with the formation of aromatic 3 
amines, is generally indicative of hard segment degradation [12,24] (Supplementary Fig. 2). 4 
As before, upon inspection of the histogram (Supplementary Fig. 2, bottom right), B0 and B3 5 
can be described as comprising a mono-modal distribution (again with similar means (0.93 6 
and 0.94) and standard deviations (0.03 and 0.04)) and B20 can be seen to comprise a bi-7 
modal distribution with a mean of 1.15 and standard deviation of 0.16 (Supplementary Fig. 8 
2). Similar to the 1248 cm-1 images, the 1650 cm-1 images are not homogeneous, with 9 
apparent outlier pixels visible in all three specimen images at the same positions as those of 10 
the 1248 cm-1 images. 11 
To further investigate the apparent outlier pixels of the single wavenumber images, 12 
individual pixels were selected from the 1650 cm-1 images and their associated spectra were 13 
visualised to assess their chemical differences (Fig. 4).  14 
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 1 
Figure 4. Spectra of pixels selected from images of relative absorbance at 1650 cm
-1
 for B0, B3 and B20.All 2 
images scaled equally (height and width). Image colour scale from 1
st
 to 99
th
 percentile. 3 
It can be seen that bright pixels indicate the presence of a greater 1650 cm-1 absorbance 4 
intensity in the associated spectrum, while the darker pixels indicate a lower absorbance 5 
intensity at the 1650 cm-1 position. Observation of the selected spectra indicates they are 6 
not truly outliers (e.g. due to errors in detection), but rather represent highly localised 7 
specimen regions with different chemical features. Cell-biomaterial interactions in these 8 
regions could vary significantly from the un-degraded surface regions, resulting in potential 9 
complications with an implant. For example, regions of degradation could act as sites for 10 
protein adhesion, leading to issues such as biofilm formation. Similar spatial features are 11 
evident when comparing the 1650 cm-1 images to the dimensionless peak ratio images 12 
(Supplementary Figures 3 and 4). In these peak ratio images, the same pixel intensity trends 13 
were observed regardless of normalisation.  14 
19 
 
Raman hyperspectral chemical maps were compared with ATR-FTIR HCIs as a means of 1 
independent corroboration of the results. Supplementary Figures 5 (B0) and 6 (B20) present 2 
mean Raman images, and ATR-FTIR images at 1650 cm-1. Changes in measured fluorescence 3 
appeared to be a major cause of the differences observed between Raman pixels. It should 4 
also be noted that features which are IR active are not equivalently active in the case of 5 
Raman spectroscopy, leading to changes in relative intensity of pixel features between 6 
modalities. Furthermore, the Raman laser footprint is considerably smaller than the ATR-7 
FTIR detection area. Therefore smaller features could be resolved by this technique. 8 
Nevertheless, similar pixel patterns, indicating spatially varying degradation, were detected 9 
with both modalities, thus corroborating the observed results. 10 
 11 
3.2 Univariate analysis of ChronoFlex C (in vitro degradation) 12 
Similar observations were made in relation to other PCU biomaterials, specifically 13 
ChronoFlex C 80A (AdvanSource Biomaterials, Wilmington, MA, USA). The HCI mean 14 
spectrum of a ChronoFlex C 80A specimen subjected to the B20 oxidation method, appears 15 
to show a subtle aromatic amine peak at 1650 cm-1 as well as a C-C cross-linking peak at 16 
1174 cm-1 (Supplementary Fig. 7, top). The peak at 1248 cm-1 may have reduced in relative 17 
intensity, however, this is difficult to determine from a single mean spectrum. When 100 18 
randomised spectra were assessed (Supplementary Fig. 7, bottom), it was found that the 19 
1248 cm-1 intensity varied considerably. To assess the pixel intensity distributions for the 20 
wavenumbers of interest, single wavenumber histograms (at 1174 cm-1, 1248 cm-1 and 1650 21 
cm-1) were generated (Supplementary Fig. 8). The corresponding single wavenumber images 22 
present the spatial arrangements of these intensity distributions (Supplementary Fig. 8). It 23 
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can be seen that, like the Bionate II 80A specimen subjected to the B20 method, there is 1 
considerable variation in the levels of material degradation detected within the sample.  2 
3.3 Univariate analysis of Bionate II (in vivo degradation)  3 
ATR mapping was also applied to a PCU component (Supplementary Fig. 9) (Bionate II 80A, 4 
DSM, Heerlen, Netherlands) explanted from a BDyn device. Mapping of in vivo specimens 5 
provides a unique insight into the authenticity of in vitro oxidation methods, particularly 6 
with respect to the spatial heterogeneity of degradation. The selected area of the PCU ring 7 
component (Supplementary Fig. 10) was magnified with 1174 cm-1, 1248 cm-1 and 1650 cm-1 8 
single wavenumber colour maps overlaid (Fig. 5). Each map was acquired by defining an 9 
acquisition matrix with regularly spaced acquisition points, where the acquistion step size 10 
was larger than the detector aperture size. While such a method does not result in a 11 
spatially contiguous image, it does allow for the spectroscopic assessment of larger 12 
specimen regions, with a relative reduction in acquisition time, allowing for use in time-13 
sensitive studies. The hyperspectral chemical maps revealed that degradation of the in vivo 14 
specimen is spatially diverse, as was also found with in vitro degradation methods. Further, 15 
the actual spatial arrangement of the degradation appears to follow a trend with respect to 16 
the PCU ring radial position. This was found to be the case for the formation of the aromatic 17 
amine peak at 1650 cm-1, the C-C cross-linking peak at 1174 cm-1 and the disappearance of 18 
the C-O-C carbonate peak found at 1248 cm-1 (Fig. 5), all of which are reported identifiers of 19 
PCU oxidative degradation. It should be noted that the regions exhibiting 1650 cm-1 20 
aromatic amine formation do not perfectly coincide with the presence of 1174 cm-1 C-C 21 
cross-linking (Fig. 5). 22 
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 1 
Figure 5. In vivo explant with single wavenumber 1174 cm
-1
, 1248 cm
-1
 and 1650 cm
-1
 maps overlaid. All 2 
images scaled equally (height and width). 3 
3.4 Multivariate analysis (Difference Spectrum Projection) 4 
Multivariate analysis was conducted according to the methodology section. The mean 5 
spectra of Bionate II 80A specimens (B0 untreated and B20 treated) are presented (Fig. 6). 6 
These spectra were defined as reference undegraded and degraded spectra respectively and 7 
were used to calculate a degradation difference spectrum (subtraction of the former from 8 
the latter) (Fig. 6). It can be seen that peaks reported in the literature as being indicative of 9 
PCU degradation (the emergence of peaks at 1174 cm -1 and 1650 cm-1, in addition to the 10 
decline of a peak at 1248 cm-1) are highlighted in this degradation difference spectrum by 11 
being above or below the baseline as appropriate. 12 
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 1 
Figure 6. Undegraded and degraded reference spectra (top) and difference spectrum calculated from the 2 
subtraction of undegraded reference from degraded reference, including baseline (bottom). 3 
The in vitro hyperspectral chemical images were projected along the degradation difference 4 
spectrum, which applied weights to each wavenumber according to the difference spectrum 5 
in Figure 6 and summed the resultant values. The output values were used to generate 6 
degradation index maps (Fig. 7). A histogram was also generated and used to investigate the 7 
distribution of the degradation indices across all images. Regions of the histogram (Fig. 7) 8 
were thresholded where populations were separable. The mean spectra of all pixels 9 
assigned to each class are presented (Fig. 8, bottom right). Through these mean spectra, it 10 
was found that the classes represented (1) undegraded, (2) degraded and (3) very degraded 11 
regions, identified according to the magnitude of the degradation peaks of interest reported 12 
in the literature. Class 1 (undegraded, blue colour in Fig. 8) exhibited a large peak at 1248 13 
cm-1 and no peaks at 1650 cm-1 and 1174 cm-1. Class 2 (degraded, red colour in Fig. 8) 14 
23 
 
exhibited a slightly smaller peak at 1248 cm-1 , increased absorption at 1650 cm-1 and a 1 
small but distinctive peak at 1174 cm-1. Class 3 (very degraded, green colour in Fig. 8) 2 
exhibited a smaller peak at 1248 cm-1 and larger peaks at 1650 cm-1 and 1174 cm-1 Several 3 
pixels representing degradation were found in the control specimen and the specimen 4 
exposed to B3 oxidation (see red and green pixels in Figure 8), although more were present 5 
in B3 than B0. Conversely, some undegraded pixels were found in the specimen exposed to 6 
B20 oxidation. 7 
 8 
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Figure 7. Degradation value images produced by projection of HCIs along degradation difference spectrum, 1 
in addition to accompanying histogram. All images scaled equally (height and width). Image colour scale 2 
from 1
st
 to 99
th
 percentile. Threshold bars added to histogram. 3 
 4 
Figure 8. B0, B3 and B20 degradation classification images (top left, top right, bottom left) with colour-coded 5 
classification mean spectra (bottom right). All images scaled equally (height and width). 6 
4. Discussion  7 
Through a novel application of HCI, this study demonstrates spatial changes in degradation 8 
across PCU biomaterial surfaces. It was found that it is possible to identify regional 9 
differences in chemical degradation, allowing for more detailed investigations. The results 10 
call into question the validity of the use of traditional point spectroscopic methods by 11 
illustrating that, in materials where heterogeneity in surface degradation exists, the 12 
acquisition of just one spectrum runs the risk of being unrepresentative of a specimen as a 13 
whole. A single spectrum can lead to subjective results as the location of spectral 14 
acquisitions can have a large effect on the ultimate conclusions drawn. The present study 15 
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has also shown that even in instances where large hyperspectral chemical images are 1 
acquired, a single mean spectrum might not represent a material as a whole. Further, a 2 
mean spectrum calculated for a large area cannot identify any sub-region of the material, as 3 
a mean spectrum is a linear combination of all, possibly very distinct, collected spectra 4 
which can result in a “blending” effect. Therefore accurate conclusions can only be drawn 5 
from HCI when combined with appropriate data processing techniques. For example, in a 6 
previous study which used point acquisition to examine chemical changes, PCUs exposed to 7 
3% H2O2 in vitro oxidative treatment showed no evidence of hard segment degradation in 8 
any of the specimens evaluated [24]. Had point spectroscopy been utilised in the present 9 
study, similar conclusions would have been drawn. However it has been demonstrated, 10 
through the generation of select wavenumber images [1174cm-1, 1248cm-1 and 1650cm-1] 11 
and associated histograms, that in some localised regions of the PCU specimen exposed to 12 
an identical treatment (B3), a peak emerges at 1650 cm-1 (indicating aromatic amine), 13 
implying the local occurrence of hard segment degradation [12,24]. Further spatial 14 
heterogeneity of degradation was observed in the case of the untreated control specimens 15 
(B0) as well as the more harshly oxidised specimens (B20). Without HCI, these chemically 16 
distinct regions would go unnoticed, or would be over-represented. The observation of 17 
locally distinct chemical regions on the B0 control specimen was unexpected and may have 18 
been caused by one or more factors including, potential inconsistencies in the biomaterial 19 
mixing/formulation/manufacture process and/or in the sterilisation of the PCU plaques. It 20 
may also be caused by mechanical factors. At this time the hard segment changes cannot be 21 
attributed to a single factor. Both Trommsdorff et al. [40] and Cipriani et al. [9] stated that, 22 
as the degradation is limited to the surface layer, the functionality [40] and the mechanical 23 
properties [9] of the entire device are unlikely to be affected. However, Lawless et al. [8] 24 
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discovered that the viscous property, of the BDyn device’s PCU component, was statistically 1 
different, at specific frequencies, after in vitro degradation [8]. 2 
Ultimately, a balance between efficiency and accuracy should be struck and with that 3 
sentiment in mind, hyperspectral chemical mapping was presented with in vivo degraded 4 
explanted specimens. While such a method does not result in a spatially contiguous image, 5 
it does allow for the spectroscopic assessment of larger specimen regions, with a relative 6 
reduction in acquisition time, allowing for use in time-sensitive studies. The hyperspectral 7 
chemical maps of the in vivo degraded PCU component revealed that degradation is 8 
spatially diverse; this was also found with in vitro degraded PCU specimens. Further, it was 9 
discovered that the regions exhibiting 1650 cm-1 aromatic amine formation (indicative of 10 
hard segment degradation [12,24]) do not perfectly coincide with the presense of 1174 cm-1 11 
C-C cross-linking (indicative of soft segment degradation [12,24]) as was found to be the 12 
case with in vitro degraded specimen, suggesting a more complex degradation mechanism 13 
than simple oxidation. In addition, it was observed that degradation heterogeneity 14 
appeared to be somewhat radially dependent, possibly due the introduction of localised 15 
mechanical stresses or enzyme action. However the cause is not currently known.  16 
Finally, a simple multivariate method was developed coined “difference spectrum 17 
projection”. This method generated and assigned a degradation index to each pixel of the in 18 
vitro-degraded PCU biomaterial specimen HCIs. Upon inspection of the degradation index 19 
distribution, it was found that the specimens comprise regions drawn from one of three 20 
distinct “degradation-level” populations. Despite the use of three different degradation 21 
protocols (including one control), heterogeneity in degradation-levels was found across the 22 
surface of each specimen, again emphasising the importance of HCI techniques. The 23 
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multivariate technique used provides many advantages over standard univariate analysis, 1 
not least: significant reductions in operator bias. It should be noted that after reference 2 
spectra are selected according to the method, all steps described required can be 3 
automated. The difference spectrum generated also has the potential to expose spectral 4 
peaks or broad bands which might not be as readily visible to a human operator and is 5 
further capable of using multiple identifier peaks in unison. 6 
5. Conclusion  7 
This study demonstrates the potential of hyperspectral chemical imaging (HCI) in the 8 
detection of spatial variation of the degradation of PCU biomaterials. The use of HCI can 9 
prevent the unavoidable introduction of subjectivity associated with traditional point 10 
spectroscopic methods and its use will lead to a deeper understanding of a biomaterial’s 11 
chemical condition in pre-implantation quality control, in vitro degradation studies and 12 
retrieval studies. It is proposed that it is now time to move the standard forward, from that 13 
of point acquisition to that of HCI. 14 
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